Hereditary Cancer Test Offerings Update

Updated Panels Based on National Guidelines, Literature and GeneDx Data


BRIP1, RAD51C, and RAD51D

Reduced Turn-Around-Time

Updated Brochures and Patient Education Material

Simplified Ordering Options

  • Removing Breast Cancer High Risk Panels from the Test Requisition Form, however, they will still be available as an orderable test as needed
  • OncoGeneDx Custom Panel maintains flexibility with simplified ordering. STK11 will remain available via the OncoGeneDx Custom Panel


Samples accessioned on or after July 18th will receive the updated testing.